Metastatic Pancreatic Neuroendocrine Carcinoma: Does Aggressive Surgical Intervention Improve Outcome?

#497

Introduction: Pancreatic neuroendocrine tumors (PNETS) often present late. At diagnosis, 65% of patients have metastases, with median survival of 24 months. The conventional approach is conservative management. Recent evidence has suggested that aggressive treatment leads to better outcomes.

Aim(s): To show that in a cohort of patients with advanced PNETs aggressive resection prolongs survival.

Materials and methods: All patients assessed for intra-abdominal NETs by the HPB and NET MDTs from 2002-Nov 2011 were prospectively registered on a database. All patients with PNETs were identified. Demographic, treatment, peri-operative morbidity and survival data were analysed using the Clavien system and SPS.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: White M, Edwards L, Cawich S, Abu-Hilal M, Armstrong T,

Keywords: pancreatic, surgery,